Lorente, D., Bianchini, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., De Bono, J. S. (2014) Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer. EUROPEAN JOURNAL OF CANCER, 50 (5). pp. 1042-1043. ISSN 0959-8049

Full text not available from this repository.

Item Type:	Letter
Authors (ICR Faculty only):	De Bono, Johann
All Authors:	Lorente, D., Bianchini, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., De Bono, J. S.
Additional Information:	ISI Document Delivery No.: AC3FI Times Cited: 0 Cited Reference Count: 8 Lorente, David Bianchini, Diletta Rodriguez-Vida, Alejo Omlin, Aurelius Pezaro, Carmel Ferraldeschi, Roberta Zivi, Andrea Attard, Gerhardt Chowdhury, Simon De Bono, Johann S. Elsevier sci ltd Oxford
Uncontrolled Keywords:	cross-resistance
Research teams:	ICR divisions > Cancer Therapeutics > Cancer Biomarkers ICR divisions > Clinical Studies > Cancer Biomarkers ICR divisions > Clinical Studies > Prostate Cancer Targeted Therapy Group
Depositing User:	Alexander Smithson
Date Deposited:	04 Apr 2014 15:57
Last Modified:	07 Jul 2017 15:48
URI:	http://publications.icr.ac.uk/id/eprint/13176

Actions (login required)

View Item